Investegate announcements from Formycon AG, Formycon is acquiring the biosimilar assets FYB201 and FYB202 and strengthening its position in the global growth market of biosimilars through long-term partnership with ATHOS KG
DGAP-News: Formycon AG / Key word(s): Mergers & Acquisitions/Agreement29.03.2022 / 18:02 The issuer is solely responsible for the content of this announcement.Press Release // March 29, 2022Formycon is acquiring the biosimilar assets FYB201 and FYB202 and strengthening its position in the global growth market of bio.